4//SEC Filing
Fairmount Healthcare Fund II L.P. 4
Accession 0001104659-25-091747
CIK 0000907654other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:33 PM ET
Size
13.6 KB
Accession
0001104659-25-091747
Insider Transaction Report
Form 4
Fairmount Funds Management LLC
Director10% Owner
Transactions
- Award
Common Stock
2025-09-17$15.00/sh+333,340$5,000,100→ 1,131,954 total(indirect: By Fairmount Healthcare Fund II L.P.)
Holdings
- 2,573,308(indirect: By Fairmount Healthcare Co-Invest III L.P.)
Common Stock
Fairmount Healthcare Co-Invest III L.P.
Director10% Owner
Transactions
- Award
Common Stock
2025-09-17$15.00/sh+333,340$5,000,100→ 1,131,954 total(indirect: By Fairmount Healthcare Fund II L.P.)
Holdings
- 2,573,308(indirect: By Fairmount Healthcare Co-Invest III L.P.)
Common Stock
Harwin Peter Evan
Director10% Owner
Transactions
- Award
Common Stock
2025-09-17$15.00/sh+333,340$5,000,100→ 1,131,954 total(indirect: By Fairmount Healthcare Fund II L.P.)
Holdings
- 2,573,308(indirect: By Fairmount Healthcare Co-Invest III L.P.)
Common Stock
Kiselak Tomas
Director10% Owner
Transactions
- Award
Common Stock
2025-09-17$15.00/sh+333,340$5,000,100→ 1,131,954 total(indirect: By Fairmount Healthcare Fund II L.P.)
Holdings
- 2,573,308(indirect: By Fairmount Healthcare Co-Invest III L.P.)
Common Stock
Fairmount Healthcare Fund II L.P.
Director10% Owner
Transactions
- Award
Common Stock
2025-09-17$15.00/sh+333,340$5,000,100→ 1,131,954 total(indirect: By Fairmount Healthcare Fund II L.P.)
Holdings
- 2,573,308(indirect: By Fairmount Healthcare Co-Invest III L.P.)
Common Stock
Footnotes (2)
- [F1]The shares of Common Stock were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended.
- [F2]Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. and Fairmount Healthcare Co-Invest III L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
Documents
Issuer
Oruka Therapeutics, Inc.
CIK 0000907654
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001769651
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:33 PM ET
- Size
- 13.6 KB